HK1043937A1 - Bpi蛋白質產品的人類醫療用途 - Google Patents

Bpi蛋白質產品的人類醫療用途

Info

Publication number
HK1043937A1
HK1043937A1 HK02104223.9A HK02104223A HK1043937A1 HK 1043937 A1 HK1043937 A1 HK 1043937A1 HK 02104223 A HK02104223 A HK 02104223A HK 1043937 A1 HK1043937 A1 HK 1043937A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic uses
protein products
human therapeutic
bpi protein
bpi
Prior art date
Application number
HK02104223.9A
Other languages
English (en)
Inventor
Friedmann Nadav
J H Van Deventer Sander
Wedel Nancy
J Scannon Patrick
A M Von Der Mohlen Marijke
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Publication of HK1043937A1 publication Critical patent/HK1043937A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
HK02104223.9A 1994-01-24 2002-06-04 Bpi蛋白質產品的人類醫療用途 HK1043937A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18822194A 1994-01-24 1994-01-24
US08/291,112 US5643875A (en) 1994-01-24 1994-08-16 Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products

Publications (1)

Publication Number Publication Date
HK1043937A1 true HK1043937A1 (zh) 2002-10-04

Family

ID=26883856

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104223.9A HK1043937A1 (zh) 1994-01-24 2002-06-04 Bpi蛋白質產品的人類醫療用途

Country Status (9)

Country Link
US (5) US5643875A (zh)
EP (2) EP0741575A1 (zh)
JP (2) JPH09508130A (zh)
CN (1) CN1145033A (zh)
AU (1) AU703728B2 (zh)
CA (1) CA2181816A1 (zh)
HK (1) HK1043937A1 (zh)
MX (1) MX9602689A (zh)
WO (1) WO1995019784A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6686332B1 (en) * 1993-10-15 2004-02-03 Xoma Corporation Method of treating depressed reticuloendothelial system function
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
NZ505070A (en) 1996-05-10 2005-01-28 Xoma Corp An in vitro method for inhibiting Neisseria meningitidis bacteria of serogroups A, B, C and W135 using BPI
EP0907372B1 (en) * 1996-05-23 2003-03-12 XOMA Technology Ltd. Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) * 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
CN1324244A (zh) 1998-10-22 2001-11-28 伊莱利利公司 治疗脓毒症的方法
MXPA01007031A (es) 1999-01-22 2004-08-12 Xoma Technology Ltd Metodo para tratar enfermedades acrdiacas cronicas.
EP1340077B1 (en) * 2000-10-17 2006-01-25 Besst-Test ApS Assay for directly detecting an inflammatory indicator in a body fluid sample
WO2002055099A2 (en) * 2000-12-01 2002-07-18 Xoma Technology Ltd Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
DE60326226D1 (de) * 2002-03-21 2009-04-02 Cayman Chemical Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
US20080306768A1 (en) * 2005-03-21 2008-12-11 Medem, Inc. Healthcare Notification Method And System Including A Healthcare Website
CN105675881A (zh) * 2009-02-06 2016-06-15 阿斯图特医药公司 肾损伤和肾衰竭的诊断及预后
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123291T1 (de) * 1987-08-11 1995-06-15 Univ New York Biologisch aktive bakterientötende/durchlässigkeitserhöhende proteinfragmente.
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5089274A (en) * 1989-02-14 1992-02-18 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
EP0563222B1 (en) * 1990-12-03 1998-02-25 New York University Biologically active bactericidal/permeability-increasing protein fragments
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
EP0722333B1 (en) * 1993-10-05 2004-06-16 XOMA Technology Ltd. Bpi-protein-products for depressed reticuloendothelial system function
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products

Also Published As

Publication number Publication date
CA2181816A1 (en) 1995-07-27
US6586400B2 (en) 2003-07-01
EP1161952A2 (en) 2001-12-12
US5643875A (en) 1997-07-01
JPH09508130A (ja) 1997-08-19
WO1995019784A1 (en) 1995-07-27
US6191112B1 (en) 2001-02-20
AU703728B2 (en) 1999-04-01
US5753620A (en) 1998-05-19
US5952302A (en) 1999-09-14
AU1694495A (en) 1995-08-08
EP1161952A3 (en) 2002-01-02
MX9602689A (es) 1997-05-31
EP0741575A1 (en) 1996-11-13
JP2006321818A (ja) 2006-11-30
CN1145033A (zh) 1997-03-12
US20020094952A1 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
HK1043937A1 (zh) Bpi蛋白質產品的人類醫療用途
ZA941773B (en) Therapeutic uses of bactericidal/permeability increasing protein products
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
AP9700919A0 (en) Modulators of body weight corresponding acids and proteins diagnostic and therapeutic uses thereof
AU6124796A (en) Appliance for the epilation of the human skin
CA2253837A1 (en) Therapeutic uses of bpi protein products for human meningococcemia
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
HU910605D0 (en) Vectors and molecules for expressing zymogenous form of human c protein
GB9412711D0 (en) Medical use of bromelain
EP0831793A4 (en) PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
GB9419021D0 (en) Therapeutic protein
PL336760A1 (en) Treatment of skin diseases
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
PL324822A1 (en) Human protein mp52 arg
HK1045103A1 (zh) Bpi蛋白質產品於bpi蛋白質不足的人體的治療用途
ZA951485B (en) Medical application of bromelain
EP0833835A4 (en) OBESITY PROTEIN INTERMEDIATE PRODUCTS, THEIR PRODUCTION AND USE
EP0540575A4 (en) Human meg-csf protein and methods
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0787795A4 (en) HUMAN TOPOISOMERASE I DNA VARIANT PROTEIN
EP0857732A4 (en) HUMAN PROTEIN ANALOGUE TO PEC-60 AND THE DNA THAT ENCODES IT
GB9512877D0 (en) Skin care product
GB9508618D0 (en) Therapeutic protein
GB9422293D0 (en) Therapeutic protein